Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2014: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
Chronic inflammatory demyelinating polyneuropathy (CIDP) is classified into several clinical subtypes such as “typical” and “atypical” CIDP, and the pathogenetic mechanisms are presumably different among the subtypes . Several CIDP-specific autoantibodies have been reported, whereas they are detected only in a small population of CIDP patients. The aim of this study was to identify novel immunological target molecules of CIDP using an unbiased proteomics-based screening approach. In this study, We identified several candidate proteins. Further examination of the role of these proteins in the pathogenesis of CIDP is required.
|